Victory Square Technologies achieved a 497% revenue growth from 2022 to 2025, ranking 58th overall on Canada's Top Growing Companies list and second among publicly traded firms. The company's growth is fueled by its healthcare infrastructure subsidiary Hydreight Technologies, along with biotech and pet health ventures. In H1 2026, Victory Square reported a 434% revenue increase compared to the previous year, signaling continued expansion. Investors gain diversified exposure to emerging tech sectors through Victory Square's portfolio, which includes established and development-stage companies.
Victory Square Technologies' ranking on Canada's Top Growing Companies list is noted here with Pluang's health sector market data as of Oct 06, 2026 18:43 WIB: out of 100 priced US health stocks, 68 rose and 24 fell today. Notable movers include Illumina, Inc. (ILMN) at USD 300.00 with a +2.15% change and a typical hold time of 84 days, Ginkgo Bioworks Holdings Inc (DNA) at USD 15.30 with a +2.14% change and a 48% Sell / 52% Buy order split, and BridgeBio Pharma Inc (BBIO) at USD 67.55 with a +2.13% change and 100% Buy order activity.
Morgan Stanley analyst Bob Huang lowered American International Group's (AIG) price target to $80 from $81, with the stock trading around $76, indicating potential upside. AIG is set to report its Q3 2026 earnings on November 3, with investors focuse...
Vertiv Holdings, a maker of power and cooling equipment for data centers, faces mixed analyst opinions with GLJ Research rating it a "Sell" and BMO Capital giving an "Outperform" rating. Despite a recent stock pullback, the company reported a 241% in...
Apogee Enterprises reported strong fiscal Q2 results with adjusted earnings of $1.17 per share, nearly double the estimated $0.59, and revenue of $391.14 million, surpassing expectations of $362.6 million. This marks a continued trend of beating esti...
McKesson received a bullish price target of $977 from Morgan Stanley, suggesting a 6.7% upside from its current price of $915.45. The company agreed to acquire Option Care Health for $32.05 per share, valuing the deal at approximately $5.8 billion in...
Ameriprise Financial has authorized an additional $5.5 billion for share repurchases through September 2028, supported by $2.1 billion in excess capital and $2.8 billion in liquidity. The company returned $1.9 billion to shareholders in H1 2026, incl...
